Cikrt M, Lepsí P, Lukás E, Sperlingová I, Horáková L, Jones M M
J Hyg Epidemiol Microbiol Immunol. 1987;31(1):31-7.
The biliary excretion of manganese, in rats which have been loaded with manganese via their drinking water, can be significantly enhanced by the administration of the chelating agents: desferrioxamine (DSF), sodium bis(hydroxyethyl) dithiocarbamate (DEDTC), and sodium isonipecotamidedithiocarbamate (INADTC). The effect of these chelating agents on the urinary excretion of manganese was more complex and was found to be dependent upon the level of loading of manganese as well as the individual chelating agent. For animals with drinking water containing 400 mg/liter of manganese, the administration of the chelating agents led to a decrease in the sum of the biliary plus urinary manganese excretion. The results are of special interest in that they show that under some conditions the administration of chelating agents can lead to changes other than those expected.
通过饮用水给大鼠负荷锰后,螯合剂去铁胺(DSF)、双(羟乙基)二硫代氨基甲酸钠(DEDTC)和异烟酰氨基二硫代甲酸钠(INADTC)的给药可显著增强大鼠胆汁中锰的排泄。这些螯合剂对锰尿排泄的影响更为复杂,发现其取决于锰的负荷水平以及个别螯合剂。对于饮用含400毫克/升锰水的动物,螯合剂的给药导致胆汁加尿中锰排泄总量减少。这些结果特别令人感兴趣,因为它们表明在某些情况下,螯合剂的给药可导致出乎预期的变化。